AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
How Marco Pharma International Preserves German Homeopathic Traditions in America 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute 
FTC Questions Apple News Over Alleged Bias Against Conservative Media 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
LONDON, Jan. 04, 2018 -- The pharmaceuticals industry is going through one of its most exciting periods yet. Generic pharmaceuticals have taken off, leading to much more innovation in the market and a wave of consolidation across the US.
Keeping on top of all these changes is Robert Wessman, CEO and founder of pharmaceuticals organisation Alvogen. His knack for spotting industry developments has seen the company soar to great heights and become a pharmaceutical leader.
Wessman recently spoke to World Finance magazine, in a three-part video series, to share his knowledge – and predictions – for the pharmaceutical market.
Though only created in 2009, Alvogen has grown substantially over the years. Wessman discusses its inception in the video series; astonishingly, the vision for Alvogen was initially sketched out on a napkin. Wessman had met investors in a New York restaurant and it was the easiest way to communicate his pharmaceutical vision. They were sold.
Today, Alvogen’s ability to thrive in one of the world’s most competitive sectors is underpinned by its fast responses to industry movements and strong team.
Later on in the video series, Wessman gives his top tips for leadership, explaining what traits are needed in order to make a business work. He also explains why it’s so important to know what you’re looking for in recruitment – so as to build the perfect team.
For some of the best insights in the generics pharmaceutical industry, go to World Finance online – where the three-part video series is available:
https://www.worldfinance.com/videos/alvogen-founder-generic-drug-price-wars-will-drive-consolidation
https://www.worldfinance.com/videos/i-took-my-napkin-and-off-we-went-robert-wessmans-billion-dollar-vision
https://www.worldfinance.com/videos/robert-wessman-a-leader-must-be-able-to-act-when-most-others-dont
World News Media is a leading publisher of quality financial and business magazines, which enjoys a global distribution network that includes subscriber lists of prominent decision-makers around the world.
CONTACT INFORMATION
World News Media
Elizabeth Matsangou
Editorial Department
+44 (0)20 7553 4162
[email protected]
